Abstract
Since 1932 the amylobarbitone (amobarbital sodium, Amytal) interview has been used as a technique for diagnostic evaluation of patients with psychiatric illnesses (Lindemann, 1932). Amytal has also been used to make mute patients talk, as a sedative, a mood elevator, and as an agent in various other types of psychiatric treatment such as sleep therapy, abreaction, narcoanalysis (Horsley, 1936), narcosynthesis (Grinkeret al.,1945), narcosuggestion, and narcoplexis (Brickneret al.,1950).

This publication has 12 references indexed in Scilit: